Skip to content

Positive screening for the use of soothing anti-itch skin lotion in patients with pruritus undergoing maintenance haemodialysis

Positive screening for the use of soothing anti-itch skin lotion in patients with pruritus undergoing maintenance haemodialysis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500112990
Enrollment
Unknown
Registered
2025-11-21
Start date
2025-11-21
Completion date
Unknown
Last updated
2025-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Maintenance hemodialysis

Interventions

This study employed a prospective, self-controlled design, with observation and assessment stratified according to the severity of patient itching (VAS score 0–10).:All participants were instructed by

Sponsors

The First Affiliated Hospital of Chengdu Medical College
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients undergoing maintenance hemodialysis (MHD) for =3 months (dialysis modality unrestricted); (2) Aged 18–75 years; (3) Self-reported pruritus with an "average pruritus score" =1 on the Chronic Dermatitis Itch Assessment Method; (4) Possessing full communication capacity and voluntarily signing an informed consent form.

Exclusion criteria

Exclusion criteria: Exclude any subject meeting any of the following criteria: (1) Individuals with a history of allergic reactions to topical dermatological medications; (2) Active infection, skin lesions, or severe inflammatory skin conditions at the study site; (3) Patients with a shortened life expectancy or those already enrolled in a kidney transplant program; (4) Individuals with severe psychiatric disorders or cognitive impairment preventing participation in the study process; (5) Participants currently enrolled in other interventional clinical trials; (6) Other circumstances where the investigator, based on medical judgment, deems participation in this study inappropriate.

Design outcomes

Primary

MeasureTime frame
VAS;

Countries

China

Contacts

Public ContactNan Mao

The First Affiliated Hospital of Chengdu Medical College

maonanlyb@163.com+86 155 2846 1208

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026